Statistics
Publications
1
Citations
29
H-Index
1
Active since
2023
Affiliations
Pfizer (United States)(Current)
Andrew Maxwell is an author at Pfizer (United States) specializing in tyrosine kinase receptors, molecular biology, and protein degradation.
Publications per year
2023–2023
1
1
A covalent BTK ternary complex compatible with targeted protein degradation
James Schiemer, Andrew Maxwell, Reto Horst et al. · Nature Communications · 2023 · 29 citations · Full text
1–1 of 1